Method for producing biaryl compound

US9624181B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9624181-B2
Application numberUS-201314424912-A
CountryUS
Kind codeB2
Filing dateAug 30, 2013
Priority dateAug 31, 2012
Publication dateApr 18, 2017
Grant dateApr 18, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The invention provides a production method of a biaryl compound of the formula [3] or a salt thereof, including reacting a 2-phenylazole derivative of the formula [1] or a salt thereof, with a benzene derivative of the formula [2] or a salt thereof in the presence of a metal catalyst, a base, and one or more of (a) a monocarboxylic acid metal salt, (b) a dicarboxylic acid metal salt, (c) a sulfonic acid metal salt, and (d) a phosphate or phosphoric amide metal salt represented by R A x P(O)(OM) y wherein each symbol is as defined herein.

First claim

Opening claim text (preview).

The invention claimed is: 1. A method of producing a biaryltetrazole compound represented by the formula [3′]: wherein R 1 to R 4 are each independently a hydrogen atom, or an alkyl group, an aralkyl group or an aryl group, each of which optionally has 1 to 5 substituents that are the same or different and that are selected from (1) halogen atom; (2) hydroxy; (3) amino; (4) nitro; (5) cyano; (6) a heterocyclic group optionally substituted by 1 to 3 substituents selected from halogen atom, hydroxy, amino, nitro, cyano, optionally halogenated C 1-6 alkyl, mono- or di-C 1-6 alkyl-amino, C 6-14 aryl, mono- or di-C 6-14 aryl-amino, C 3-8 cycloalkyl, C 1-6 alkoxy, C 1-6 alkoxy-C 1-6 alkoxy, C 1-6 alkylsulfanyl, C 1-6 alkylsulfinyl, C 1-6 alkylsulfonyl, optionally esterified carboxy, carbamoyl, thiocarbamoyl, mono- or di-C 1-6 alkyl-carbamoyl, mono- or di-C 6-14 aryl-carbamoyl, sulfamoyl, mono- or di-C 1-6 alkyl-sulfamoyl, and mono- or di-C 6-14 aryl-sulfamoyl; (7) mono- or di-C 1-6 alkyl-amino; (8) mono- or di-C 6-14 aryl-amino; (9) mono- or di-C 7-14 aralkyl-amino; (10) N-C 1-6 alkyl-N-C 6-14 aryl-amino; (11) N-C 1-6 alkyl-N-C 7-14 aralkyl-amino; (12) C 3-8 cycloalkyl; (13) optionally halogenated C 1-6 alkoxy; (14) C 1-6 alkylsulfanyl; (15) C 1-6 alkylsulfinyl; (16) C 1-6 alkylsulfonyl; (17) optionally esterified carboxy; (18) C 1-6 alkyl-carbonyl; (19) C 3-8 cycloalkyl-carbonyl; (20) C 6-14 aryl-carbonyl; (21) carbamoyl; (22) thiocarbamoyl; (23) mono- or di-C 1-6 alkyl-carbamoyl; (24) mono- or di-C 6-14 aryl-carbamoyl; (25) N-C 1-6 alkyl-N-C 6-14 aryl-carbamoyl; (26) mono- or di-5- to 7-membered heterocyclyl-carbamoyl; (27) C 1-6 alkyl-carbonylamino optionally substituted by carboxy; (28) C 6-14 aryloxy optionally substituted by 1 to 3 substituents selected from halogen atom, hydroxy, amino, nitro, cyano, optionally halogenated C 1-6 alkyl, mono- or di-C 1-6 alkyl-amino, C 6-14 aryl, mono- or di-C 6-14 aryl-amino, C 3-8 cycloalkyl, C 1-6 alkoxy, C 1-6 alkoxy-C 1-6 alkoxy, C 1-6 alkylsulfanyl, C 1-6 alkylsulfinyl, C 1-6 alkylsulfonyl, optionally esterified carboxy, carbamoyl, thiocarbamoyl, mono- or di-C 1-6 alkyl-carbamoyl, mono- or di-C 6-14 aryl-carbamoyl, sulfamoyl, mono- or di-C 1-6 alkyl-sulfamoyl and mono- or di-C 6-14 aryl-sulfamoyl; (29) C 6-14 aryl optionally substituted by 1 to 3 substituents selected from halogen atom, hydroxy, amino, nitro, cyano, optionally halogenated C 1-6 alkyl, mono- or di-C 1-6 alkyl-amino, C 6-14 aryl, mono- or di-C 6-14 aryl-amino, C 3-8 cycloalkyl, C 1-6 alkoxy, C 1-6 alkoxy-C 1-6 alkoxy, C 1-6 alkylsulfanyl, C 1-6 alkylsulfinyl, C 1-6 alkylsulfonyl, optionally esterified carboxy, carbamoyl, thiocarbamoyl, mono- or di-C 1-6 alkyl-carbamoyl, mono- or di-C 6-14 aryl-carbamoyl, sulfamoyl, mono- or di-C 1-6 alkyl-sulfamoyl and mono- or di-C 6-14 aryl-sulfamoyl; (30) heterocyclyl-oxy; (31) sulfamoyl; (32) mono- or di-C 1-6 alkyl-sulfamoyl; (33) mono- or di-C 6-14 aryl-sulfamoyl; (34) C 7-14 aralkyloxy optionally substituted by 1 to 3 substituents selected from halogen atom, hydroxy, amino, nitro, cyano, optionally halogenated C 1-6 alkyl, mono- or di-C 1-6 alkyl-amino, C 6-14 aryl, mono- or di-C 6-14 aryl-amino, C 3-8 cycloalkyl, C 1-6 alkoxy, C 1-6 alkoxy-C 1-6 alkoxy, C 1-6 alkylsulfanyl, C 1-6 alkylsulfinyl, C 1-6 alkylsulfonyl, optionally esterified carboxy, carbamoyl, thiocarbamoyl, mono- or di-C 1-6 alkyl-carbamoyl, mono- or di-C 6-14 aryl-carbamoyl, sulfamoyl, mono- or di-C 1-6 alkyl-sulfamoyl and mono- or di-C 6-14 aryl-sulfamoyl; (35) C 1-6 alkyl-carbonyloxy; (36) C 1-6 alkoxy-carbonyl; and (37) tri-C 1-6 alkylsilyloxy; R 5′ is a methyl group, a methyl group substituted by a protected hydroxyl group, or a lower alkoxycarbonyl group, and R 6 is a tetrazolyl-protecting group, or a salt thereof, comprising reacting a 2-phenylazole derivative represented by the formula [1′]: wherein R 1 to R 4 are each independently a hydrogen atom, or an alkyl group, an aralkyl group or an aryl group, each of which optionally has 1 to 5 substituents that are the same or different and that are selected from (1) halogen atom; (2) hydroxy; (3) amino; (4) nitro; (5) cyano; (6) a heterocyclic group optionally substituted by 1 to 3 substituents selected from halogen atom, hydroxy, amino, nitro, cyano, optionally halogenated C 1-6 alkyl, mono- or di-C 1-6 alkyl-amino, C 6-14 aryl, mono- or di-C 6-14 aryl-amino, C 3-8 cycloalkyl, C 1-6 alkoxy, C 1-6 alkoxy-C 1-6 alkoxy, C 1-6 alkylsulfanyl, C 1-6 alkylsulfinyl, C 1-6 alkylsulfonyl, optionally esterified carboxy, carbamoyl, thiocarbamoyl, mono- or di-C 1-6 alkyl-carbamoyl, mono- or di-C 6-14 aryl-carbamoyl, sulfamoyl, mono- or di-C 1-6 alkyl-sulfamoyl, and mono- or di-C 6-14 aryl-sulfamoyl; (7) mono- or di-C 1-6 alkyl-amino; (8) mono- or di-C 6-14 aryl-amino; (9) mono- or di-C 7-14 aralkyl-amino; (10) N-C 1-6 alkyl-N-C 6-14 aryl-amino; (11) N-C 1-6 alkyl-N-C 7-14 aralkyl-amino; (12) C 3-8 cycloalkyl; (13) optionally halogenated C 1-6 alkoxy; (14) C 1-6 alkylsulfanyl; (15) C 1-6 alkylsulfinyl; (16) C 1-6 alkylsulfonyl; (17) optionally esterified carboxy; (18) C 1-6 alkyl-carbonyl; (19) C 3-8 cycloalkyl-carbonyl; (20) C 6-14 aryl-carbonyl; (21) carbamoyl; (22) thiocarbamoyl; (23) mono- or di-C 1-6 alkyl-carbamoyl; (24) mono- or di-C 6-14 aryl-carbamoyl; (25) N-C 1-6 alkyl-N-C 6-14 aryl-carbamoyl; (26) mono- or di-5- to 7-membered heterocyclyl-carbamoyl; (27) C 1-6 alkyl-carbonylamino optionally substituted by carboxy; (28) C 6-14 aryloxy optionally substituted by 1 to 3 substituents selected from halogen atom, hydroxy, amino, nitro, cyano, optionally halogenated C 1-6 alkyl, mono- or di-C 1-6 alkyl-amino, C 6-14 aryl, mono- or di-C 6-14 aryl-amino, C 3-8 cycloalkyl, C 1-6 alkoxy, C 1-6 alkoxy-C 1-6 alkoxy, C 1-6 alkylsulfanyl, C 1-6 alkylsulfinyl, C 1-6 alkylsulfonyl, optionally esterified carboxy, carbamoyl, thiocarbamoyl, mono- or di-C 1-6 alkyl-carbamoyl, mono- or di-C 6-14 aryl-carbamoyl, sulfamoyl, mono- or di-C 1-6 alkyl-sulfamoyl and mono- or di-C 6-14 aryl-sulfamoyl; (29) C 6-14 aryl optionally substituted by 1 to 3 substituents selected from halogen atom, hydroxy, amino, nitro, cyano, optionally halogenated C 1-6 alkyl, mono- or di-C 1-6 alkyl-amino, C 6-14 aryl, mono- or di-C 6-14 aryl-amino, C 3-8 cycloalkyl, C 1-6 alkoxy, C 1-6 alkoxy-C 1-6 alkoxy, C 1-6 alkylsulfanyl, C 1-6 alkylsulfinyl, C 1-6 alkylsulfonyl, optionally esterified carboxy, carbamoyl, thiocarbamoyl, mono- or di-C 1-6 alkyl-carbamoyl, mono- or di-C 6-14 aryl-carbamoyl, sulfamoyl, mono- or di-C 1-6 alkyl-sulfamoyl and mono- or di-C 6-14 aryl-sulfamoyl; (30) heterocyclyl-oxy; (31) sulfamoyl; (32) mono- or di-C 1-6 alkyl-sulfamoyl; (33) mono- or di-C 6-14 aryl-sulfamoyl; (34) C 7-14 aralkyloxy optionally substituted by 1 to 3 substituents selected from halogen atom, hydroxy, amino, nitro, cyano, optionally halogenated C 1-6 alkyl, mono- or di-C 1-6 alkyl-amino, C 6-14 aryl, mono- or di-C 6-14 aryl-amino, C 3-8 cycloalkyl, C 1-6 alkoxy, C 1-6 alkoxy-C 1-6 alkoxy, C 1-6 alkylsulfanyl, C 1-6 alkylsulfinyl, C 1-6 alkylsulfonyl, optionally esterified carboxy, carbamoyl, thiocarbamoyl, mono- or di-C 1-6 alkyl-carbamoyl, mono- or di-C 6-14 aryl-carbamoyl, sulfamoyl, mono- or di-C 1-6 alkyl-sulfamoyl and mono- or di-C 6-14 aryl-sulfamoyl; (35) C 1-6 alkyl-carbonyloxy; (36) C 1-6 alkoxy-carbonyl; and (37) tri-C 1-6 alkylsilyloxy; and R 6 is a tetrazo

Assignees

Inventors

Classifications

  • C07D257/04Primary

    Five-membered rings · CPC title

  • Substitution · CPC title

  • linked by a carbon chain containing aromatic rings · CPC title

  • containing three or more hetero rings · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9624181B2 cover?
The invention provides a production method of a biaryl compound of the formula [3] or a salt thereof, including reacting a 2-phenylazole derivative of the formula [1] or a salt thereof, with a benzene derivative of the formula [2] or a salt thereof in the presence of a metal catalyst, a base, and one or more of (a) a monocarboxylic acid metal salt, (b) a dicarboxylic acid metal salt, (c) a sulf…
Who is the assignee on this patent?
Api Corp
What technology area does this patent fall under?
Primary CPC classification C07D257/04. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Apr 18 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).